grant

Patient-reported outcomes and treatment preferences in 1,900 men with prostate cancer participating in two international, randomised clinical trials [ 2018 - 2022 ]


Funded by National Health and Medical Research Council
Managed by University of Sydney
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1138100]

Brief description Men with high-risk or metastatic prostate cancer are faced with difficult and uncertain trade-offs between quantity and quality of life when making a treatment decision. The proposed study extends two promising, ongoing clinical trials by describing the quality of life outcomes and treatment.

Funding Amount $AUD 327,193.32

Funding Scheme Early Career Fellowships

Notes Public Health (Australia) ECF

Click to explore relationships graph
Help

Related Organisations

Subjects
Cancer Therapy (Excl. Chemotherapy and Radiation Therapy) | Medical and Health Sciences | Oncology and Carcinogenesis | consumer preferences | outcome assessment | outcome measures | prostate cancer | quality of life |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA
ACN 633 798 857